Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim is to assess the response of cardiac output and stroke volume to volume preload optimization in patients with severe aortic stenosis treated with aortic prosthesis implantation.
Patients with severe aortic stenosis present a maintained overload pressure of the left ventricle that can lead to a progressive hypertrophy. This results in elevated left-sided filling pressures and impaired diastolic function.In this context, paradoxical changes in left ventricular function after aortic valve replacement have been described, with acute decrease of the afterload condition that can result in the development of a dynamic intraventricular gradient, especially in the presence of small ventricles with severe hypertrophy, resulting in hemodynamic collapse.
In this setting, it is particularly important to ensure accurate left ventricular preload to optimize myocardial contractility and guarantee an adequate hemodynamic response to valve implantation.
Patients with severe aortic stenosis submitted for transfemoral TAVI on spontaneous breathing will be randomly assigned 1:1 to standard care vs volume preload optimization. Non-invasive continuous monitoring (Clear Sight System, Edwards Lifesciences) will be used to evaluate the cardiac output and the stroke volume in both groups, comparing the hemodynamics before and after valve implant.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Volume preload optimization. | Experimental | Volume overload with 250 cc saline solution will be performed in the intervention arm, verifying the response of the cardiac output and stroke volume with non invasive continue monitoring. |
|
| Control group | No Intervention | Standard care without volume preload. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Colloid preload | Other | 250 cc of colloid preload solution will be infused in the intervention group |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cardiac output after valve implant | Cardiac output (l/min) after TAVI | "1 year" |
| Measure | Description | Time Frame |
|---|---|---|
| Stroke volume after valve implant | SV (ml) after TAVI | "1 year" |
| Measure | Description | Time Frame |
|---|---|---|
| Need of inotropes | Yes/no | "1 year" |
| HR after TAVI | rpm | "1 year" |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Leire Unzue, PhD | Contact | 0034917089900 | leireunzue@yahoo.es | |
| Miguel Rodríguez del Río, MD | Contact | 0034917089900 | mrrio1980@gmail.com |
Not provided
Not provided
Not provided
At recruitment and after study conclusion
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided